Literature DB >> 1737851

Pathobiology of cast nephropathy from human Bence Jones proteins.

P W Sanders1, B B Booker.   

Abstract

Renal failure is a common accompaniment of multiple myeloma and is usually due to cast nephropathy, or "myeloma kidney." To understand this lesion, four human Bence Jones proteins (BJP) were purified from the urine of volunteers who had either no evidence of renal dysfunction (BJP1) or renal failure from cast nephropathy (BJP2, BJP3, BJP4). When infused directly into the rat nephron in vivo, BJP2, BJP3, and BJP4 produced intraluminal obstruction by precipitating in the distal nephron; protein casts were never identified before the tip of the loop of Henle. Obstruction was related to the concentration of BJP in the perfusate. Addition of furosemide to the perfusate augmented obstruction in a concentration-dependent fashion. Pretreatment of rats with colchicine completely prevented obstruction and cast formation of perfused nephrons; beta-lumicolchicine did not prevent obstruction. Tamm-Horsfall glycoprotein purified from beta-lumicolchicine-treated and untreated rats coaggregated with BJP3 in vitro. Tamm-Horsfall glycoprotein from colchicine-treated rats did not contain sialic acid and did not aggregate with BJP3 in vitro. Thus, cast-forming human BJP coaggregated with Tamm-Horsfall glycoprotein and obstructed the rat distal nephron. Intranephronal obstruction was aggravated by decreasing extracellular fluid volume or adding furosemide. Finally, by decreasing secretion and altering the carbohydrate moiety of Tamm-Horsfall glycoprotein, colchicine prevented intraluminal cast formation and obstruction of the rat nephron.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737851      PMCID: PMC442896          DOI: 10.1172/JCI115629

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  BENCE JONES PROTEINEMIA.

Authors:  A SOLOMON; J L FAHEY
Journal:  Am J Med       Date:  1964-08       Impact factor: 4.965

2.  STUDIES OF THIRTY DIFFERENT BENCE JONES PROTEIN-PRODUCING PLASMA CELL NEOPLASMS IN AN INBRED STRAIN OF MOUSE.

Authors:  K R MCINTIRE; M POTTER
Journal:  J Natl Cancer Inst       Date:  1964-10       Impact factor: 13.506

3.  The nature of urinary casts.

Authors:  E G McQueen
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

4.  Characterization and separation of an inhibitor of viral hemagglutination present in urine.

Authors:  I TAMM; F L HORSFALL
Journal:  Proc Soc Exp Biol Med       Date:  1950-05

5.  Effect of sustained diuresis on the renal lesions of mice with Bence Jones protein-producing tumors.

Authors:  C W Bryan; K R McIntire
Journal:  J Lab Clin Med       Date:  1974-03

Review 6.  Bence-Jones proteins and light chains of immunoglobulins (first of two parts).

Authors:  A Solomon
Journal:  N Engl J Med       Date:  1976-01-01       Impact factor: 91.245

7.  Multiple myeloma: review of 869 cases.

Authors:  R A Kyle
Journal:  Mayo Clin Proc       Date:  1975-01       Impact factor: 7.616

8.  Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition.

Authors:  P W Sanders; G A Herrera; K A Kirk; C W Old; J H Galla
Journal:  Lab Invest       Date:  1991-04       Impact factor: 5.662

9.  Nephrotoxic potential of Bence Jones proteins.

Authors:  A Solomon; D T Weiss; A A Kattine
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

10.  The nature of Bence-Jones proteins. Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins.

Authors:  G M EDELMAN; J A GALLY
Journal:  J Exp Med       Date:  1962-08-01       Impact factor: 14.307

View more
  45 in total

1.  Pivotal role of apoptosis signal-regulating kinase 1 in monoclonal free light chain-mediated apoptosis.

Authors:  Wei-Zhong Ying; Pei-Xuan Wang; Paul W Sanders
Journal:  Am J Pathol       Date:  2011-11-10       Impact factor: 4.307

Review 2.  The pathogenesis and diagnosis of acute kidney injury in multiple myeloma.

Authors:  Colin A Hutchison; Vecihi Batuman; Judith Behrens; Frank Bridoux; Christophe Sirac; Angela Dispenzieri; Guillermo A Herrera; Helen Lachmann; Paul W Sanders
Journal:  Nat Rev Nephrol       Date:  2011-11-01       Impact factor: 28.314

3.  Multiple myeloma presenting as acute renal failure.

Authors:  Vincent C Kuo; Andrew Z Fenves; Ankit N Mehta
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-10

Review 4.  Uromodulin in kidney injury: an instigator, bystander, or protector?

Authors:  Tarek M El-Achkar; Xue-Ru Wu
Journal:  Am J Kidney Dis       Date:  2012-01-23       Impact factor: 8.860

Review 5.  Myeloma light chain cast nephropathy, a review.

Authors:  Insara Jaffer Sathick; Maria Eleni Drosou; Nelson Leung
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

6.  Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein.

Authors:  Z Q Huang; P W Sanders
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

7.  Electrophoretic study of the physico-chemical characteristics of Bence-Jones proteinuria and its association with kidney damage.

Authors:  M C Diemert; L Musset; O Gaillard; S Escolano; A Baumelou; F Rousselet; J Galli
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

Review 8.  Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney-What We Know and What the Future May Hold.

Authors:  Sandhya Manohar; Samih H Nasr; Nelson Leung
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

Review 9.  Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?

Authors:  Mona Doshi; Amit Lahoti; Farhad R Danesh; Vecihi Batuman; Paul W Sanders
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

Review 10.  Dysproteinemias and Glomerular Disease.

Authors:  Nelson Leung; Maria E Drosou; Samih H Nasr
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-07       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.